Institutional Review Board Statement
MAY
The study was conducted in accordance with the Declaration of Helsinki, approved by the Institutional Review Board of Advarra Inc. (protocol code #Pro00032192. 13 May 2019) and registered at clinicaltrials.gov (#NCT05743855).